Confounding Factors in Noninvasive Prenatal Testing under Common Benign Gynecologic Conditions

Please use this identifier to cite or link to this item: https://ir.swu.ac.th/jspui/handle/123456789/27633

Full metadata record

DC Field	Value	Language
dc.contributor.author	Hanprasertpong T.
dc.date.accessioned	2022-12-14T03:17:50Z	-
dc.date.available	2022-12-14T03:17:50Z	-
dc.date.issued	2022
dc.identifier.issn	8576084
dc.identifier.uri	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85128972138&partnerID=40&md5=4b7dd7c5a8b801eaca207531aa367858
dc.identifier.uri	https://ir.swu.ac.th/jspui/handle/123456789/27633	-
dc.description.abstract	Noninvasive prenatal testing (NIPT) is increasing in use in obstetric practice worldwide, including in Thailand. While the efficacy of NIPT for prenatal aneuploidy detection is accepted, there are some pathologic conditions that can interfere with the NIPT result, such as maternal autoimmune disease or malignancies. Interestingly, some common benign gynecologic conditions, including uterine myoma, endometriosis, and mature ovarian cystic teratoma, have been reported to be confounding effects of maternal cell-free dexoxy ribonucleic acid (DNA) on the NIPT result. © 2022 Royal Thai College of Obstetricians and Gynaecologists. All Rights Reserved.
dc.language	en
dc.publisher	Royal Thai College of Obstetricians and Gynaecologists
dc.subject	noninvasive prenatal testing (NIPT)
dc.subject	cell-free DNA (cf-DNA)
dc.title	Confounding Factors in Noninvasive Prenatal Testing under Common Benign Gynecologic Conditions
dc.type	Article
dc.rights.holder	Scopus
dc.identifier.bibliograpycitation	Journal of Emergency Medicine. Vol 63, No.2 (2022), p.309-316
Appears in Collections:	Scopus 2022

Files in This Item:

There are no files associated with this item.